Free
External
mRNA is moving beyond vaccines, emerging as a powerful platform for precise, transient protein expression across diverse disease areas. This webinar highlights advances in mRNA design and stability, including optimized UTRs, nucleoside modifications, and next-generation modalities like sa-RNA and circ-RNA. Gain insights into how new LNP technologies are unlocking tissue-targeted delivery, opening new possibilities for mRNA therapeutics.
